CUSIP: 03528H109
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,258,614
-
Total 13F shares
-
5,655,725
-
Share change
-
+274,463
-
Total reported value
-
$17,642,741
-
Price per share
-
$3.12
-
Number of holders
-
70
-
Value change
-
+$853,166
-
Number of buys
-
30
-
Number of sells
-
20
Quarterly Holders Quick Answers
What is CUSIP 03528H109?
CUSIP 03528H109 identifies ANIX - Anixa Biosciences Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 03528H109:
Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q4 2025
As of 31 Dec 2025,
Anixa Biosciences Inc - Common Stock (ANIX) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,655,725 shares.
The largest 10 holders included
VANGUARD GROUP INC, Laird Norton Wetherby Trust Company, LLC, D.A. DAVIDSON & CO., UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MISSION WEALTH MANAGEMENT, LP, BlackRock, Inc., STATE STREET CORP, and 683 Capital Management, LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.